Tyrosine kinase inhibitor suppresses the (re)stenotic changes of the coronary artery after balloon injury in pigs

Cardiovascular Research

Volumn 32, Issue 6, 1996, Pages 1131-1140

  Fukumoto, Yoshihiro ^a   Shimokawa, Hiroaki ^a   Kozai, Toshiyuki ^a   Kadokami, Toshiaki ^a   Kuwata, Kouichi ^a   Owada, M Koji ^b   Shiraishi, Tadayoshi ^c   Kuga, Takeshi ^a   Egashira, Kensuke ^a   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^c KANEKA CORPORATION   (Japan)

Author keywords

arteriosclerosis; balloon injury; coronary angioplasty; coronary artery tone; pig, coronary artery; restenosis; tyrosine kinase

Indexed keywords

ALPHA CYANO 3 ETHOXY 4 HYDROXY 5 (PHENYLTHIOMETHYL)CINNAMAMIDE; GLYCERYL TRINITRATE; HISTAMINE; PROSTAGLANDIN F2 ALPHA; PROTEIN TYROSINE KINASE INHIBITOR; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BALLOON DILATATION; CORONARY ARTERY; DRUG BIOAVAILABILITY; HEMODYNAMICS; HISTOPATHOLOGY; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; SWINE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CINNAMATES; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DISEASE MODELS, ANIMAL; MALE; PROTEIN-TYROSINE KINASES; RECURRENCE; SULFIDES; SWINE;

EID: 17744402596     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00178-2     Document Type: Article

References (36)

1. Popma JJ, Topol EJ. Factors influencing restenosis after coronary angioplasty. Am J Med. 88:1990;1N-16N.
2. Hillegass AB, Ohman EM, Calif RM. Restenosis: the clinical issues. In: Topol EJ, ed. Textbook of Interventional Cardiology, 2nd edn. Philadelphia: Saunders, 1994: 415-435.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
4. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: Have we been aiming at the wrong target? J Am Coll Cardiol. 25:1995;516-520.
5. Waller BF, Pinkerton CA, Orr CM, Slack JD, Vantassel JW, Peters T. Restenosis 1 to 24 months after clinically successful coronary balloon angioplasty: a necropsy study of 20 patients. J Am Coll Cardiol. 17:1991;58B-70B.
6. Liu MW, Roubin GS, King SB III. Restenosis after coronary angioplasty: potential biologic determinants and role of intimal hyperplasia. Circulation. 79:1989;1374-1387.
7. Grotendorst GR, Chang T, Seppa HEJ, Kleinman HK, Martin GR. Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells. J Cell Physiol. 113:1982;261-266.
8. Banskota NK, Taub R, Zellner K, Olsen P, King GL. Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I. Diabetes. 38:1989;123-129.
9. Senior RM, Griffin GL, Mecham RP. Chemotactic responses of fibroblasts to tropoelastin and elastin-derived peptides. J Clin Invest. 70:1982;614-618.
10. Postlethwaite AE, Seyer JM, Kang AH. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci USA. 75:1978;871-875.
11. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 15:1990;1667-1687.
12. Franklin SM, Faxon DP. Pharmacologic prevention of restenosis after coronary angioplasty: review of the randomized clinical trials. Coronary Art Dis. 4:1993;232-242.
13. Wang JYJ, McWhiter JR. Tyrosine-kinase-dependent signaling pathways. Trends Cardiovasc Med. 4:1994;264-270.
14. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212.
15. Shimokawa H, Ito A, Fukumoto Y, et al. Chronic treatment with interleukin-1β induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. J Clin Invest. 97:1996;769-776.
16. Ito A, Shimokawa H, Kadokami T, et al. Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1β in pigs in vivo. J Clin Invest. 96:1995;1288-1294.
17. Shimokawa H, Tomoike H, Nabeyama S, et al. Coronary artery spasm induced in atherosclerotic miniature swine. Science. 221:1983;560-562.
18. Shimokawa H, Tomoike H, Nabeyama S, et al. Coronary artery spasm induced in miniature swine: Angiographic evidence and relation to coronary atherosclerosis. Am Heart J. 110:1985;300-310.
19. Shiraishi T, Domoto T, Imai N, Shimada Y, Watanabe K. Specific inhibitors of tyrosine-specific protein kinase, synthetic 4-hydroxy-cinnamamide derivatives. Biochem Biophys Res Commun. 147:1987;322-328.
20. Schneider JE, Berk BC, Gravanis MB, et al. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. Circulation. 88:1993;628-637.
21. Ito A, Shimokawa H, Nakaike R, et al. Role of protein kinase C-mediated pathway in the pathogenesis of coronary artery spasm in a swine model. Circulation. 90:1994;2425-2431.
22. Glenney JR, Chen WS, Lazar CS, et al. Ligand-induced endocytoses of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies. J Clin Invest. 52:1988;675-684.
23. Owada MK, Iwamoto M, Koike T, Kato Y. Effects of vanadate on tyrosine phosphorylation and the pattern on tyrosine phosphorylation and the pattern of glycosaminoglycan synthesis in rabbit chondrocytes in culture. J Cell Physiol. 138:1989;484-492.
24. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 253:1991;1129-1132.
25. Linder V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA. 88:1991;3739-3743.
26. Grant MB, Wargovich TJ, Ellis EA, Cabellero S, Mansour M, Pepine CJ. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis? Circulation. 89:1994;1511-1517.
27. Ek B, Westemark B, Wasteson A, Heldin CH. Stimulation of tyrosine-specific phosphorylation by platelet-derived growth factor. Nature (Lond). 295:1982;419-420.
28. Hanks SK, Quinn AM, Hunter T. The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science. 241:1988;42-52.
29. Heldin CH, Westermark B. Platelet-derived growth factor: mechanism of action and possible in vivo function. Cell Regul. 1:1990;555-566.
30. Kawamoto T, Sato JD, Le A, Polikoff J, Sato GH, Medelsohn J. Growth stimulation of A431 cells by epidermal growth factor: Identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci USA. 80:1983;1337-1341.
31. Shiraishi T, Owada MK, Tatsuka M, Yamashita T, Watanabe K, Kakunaga T. Specific inhibitor of tyrosine-specific protein kinases: Properties of 4-hydroxycinnamamide derivatives in vitro. Cancer Res. 49:1989;2374-2378.
32. Di Mario C, Gil R, Camenzind E, et al. Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous tramsluminal coronary angioplasty and directional coronary atherectomy. Am J Cardiol. 75:1995;772-777.
33. Pasterkamp G, Wensing PJW, Post MJ, Hillen B, Mali WPTM, Borst C. Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atheroscelrotic femoral arteries. Circulation. 91:1995;1444-1449.
34. Kadokami T, Shimokawa H, Fukumoto Y, et al. Coronary artery spasm does not depend on the intracellular calcium store but is substantially mediated by the protein kinase C-mediated pathway is a swine model with interleukin-1β in vivo. Circulation. 94:1996;190-196.
35. Wanibuchi H, Dingemans KP, Becker AE, et al. Is the Watanabe heritable hyperlipidemic rabbit a suitable model for percutaneous transluminal coronary angioplasty in humans? A light microscopic, immunohistochemical and ultrastructural study. J Am Coll Cardiol. 21:1993;1490-1496.
36. Block PC, Baughman KL, Pasternak RC, Fallon JT. Transluminal angioplasty correlation of morphologic and angiographic findings in an experimental model. Circulation. 61:1980;778-785.